Medicine and Dentistry
Antiphospholipid Syndrome
100%
Rheumatic Disease
44%
Antiphospholipid Antibody
44%
Systemic Lupus Erythematosus
37%
Obstetrics
24%
Prevalence
21%
Heparin
19%
Acetylsalicylic Acid
18%
Diseases
17%
Musculoskeletal Disease
15%
Hydroxychloroquine
14%
Rheumatology
14%
Connective Tissue Disease
14%
Pre-Eclampsia
13%
Vitamin K Antagonist
12%
Pregnancy Complication
12%
Chronic Kidney Disease
10%
Disease Course
10%
Spontaneous Abortion
9%
Infection
9%
Inflammatory Arthritis
9%
Systematic Review
9%
Lupus Erythematosus
8%
Anticoagulation
8%
Rheumatoid Arthritis
8%
Placebo
8%
Disease Activity
8%
Low Drug Dose
8%
Stillbirth
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Cardiovascular Risk
8%
COVID-19
8%
Prospective Study
7%
Cohort Analysis
7%
Immunogenicity
7%
Household
7%
Phlebothrombosis
7%
Social Determinants of Health
7%
Health Inequality
7%
Brain Ischemia
7%
Livedo reticularis
7%
Livedo
7%
Humoral Immunity
7%
Risk Stratification
7%
Acute Heart Infarction
7%
Prospective Cohort Study
7%
Direct Oral Anticoagulant
7%
Apoplexy
7%
Ankle Brachial Index
7%
Inflammatory Disorder
7%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatic Disease
42%
Antiphospholipid Syndrome
38%
Antiphospholipid Antibody
26%
Acetylsalicylic Acid
17%
Heparin
17%
Hydroxychloroquine
16%
Diseases
15%
Clinical Trial
15%
Multiple Sclerosis
14%
Antivitamin K
12%
Infection
11%
Inflammatory Arthritis
9%
Autoimmune Disease
9%
COVID-19 Vaccine
8%
Rheumatoid Arthritis
8%
Prevalence
8%
Cohort Study
8%
SARS Coronavirus
8%
Prospective Cohort Study
8%
Musculoskeletal Disease
7%
Prospective Study
7%
Antirheumatic Agent
7%
Immunogenicity
7%
Acute Heart Infarction
7%
Direct Oral Anticoagulant
7%
Brain Ischemia
7%
Placebo
7%
Alemtuzumab
7%
Chronic Kidney Failure
7%
Anticoagulant Agent
7%
Dexamethasone
7%
Erythropoietin
7%
Cerebrovascular Accident
7%
Vasculitis
7%
Connective Tissue Disease
7%
Immunosuppressive Agent
6%
Adverse Event
6%
Pandemic
6%
Thrombosis
5%
Immunology and Microbiology
Antiphospholipid Syndrome
66%
Antiphospholipid Antibody
39%
Rheumatic Disease
30%
Systemic Lupus Erythematosus
22%
Hydroxychloroquine
15%
Prevalence
14%
Connective Tissue
11%
Thrombin
8%
Low Drug Dose
7%
Alemtuzumab
7%
Humoral Immunity
7%
Antibody Specificity
7%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
Immunogenicity
7%
Undifferentiated Connective Tissue Disease
7%
Thrombocyte Activation
7%
Multiple Sclerosis
7%
Offspring
7%
Vasculitis
7%
Glycoprotein
5%
Autoimmune Disease
5%